191 related articles for article (PubMed ID: 28758902)
21. CP-31398 inhibits the growth of p53-mutated liver cancer cells in vitro and in vivo.
He XX; Zhang YN; Yan JW; Yan JJ; Wu Q; Song YH
Tumour Biol; 2016 Jan; 37(1):807-15. PubMed ID: 26250460
[TBL] [Abstract][Full Text] [Related]
22. Recombinant adenovirus carrying the hepatocyte nuclear factor-1alpha gene inhibits hepatocellular carcinoma xenograft growth in mice.
Zeng X; Lin Y; Yin C; Zhang X; Ning BF; Zhang Q; Zhang JP; Qiu L; Qin XR; Chen YX; Xie WF
Hepatology; 2011 Dec; 54(6):2036-47. PubMed ID: 21898499
[TBL] [Abstract][Full Text] [Related]
23. Depletion of three combined THOC5 mRNA export protein target genes synergistically induces human hepatocellular carcinoma cell death.
Saran S; Tran DD; Ewald F; Koch A; Hoffmann A; Koch M; Nashan B; Tamura T
Oncogene; 2016 Jul; 35(29):3872-9. PubMed ID: 26549021
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N
Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076
[TBL] [Abstract][Full Text] [Related]
25. Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma.
Inoue M; Takahashi Y; Fujii T; Kitagawa M; Fukusato T
World J Gastroenterol; 2014 Dec; 20(46):17541-51. PubMed ID: 25516669
[TBL] [Abstract][Full Text] [Related]
26. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
27. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors.
Huang P; He Z; Ji S; Sun H; Xiang D; Liu C; Hu Y; Wang X; Hui L
Nature; 2011 May; 475(7356):386-9. PubMed ID: 21562492
[TBL] [Abstract][Full Text] [Related]
28. ARID1A represses hepatocellular carcinoma cell proliferation and migration through lncRNA MVIH.
Cheng S; Wang L; Deng CH; Du SC; Han ZG
Biochem Biophys Res Commun; 2017 Sep; 491(1):178-182. PubMed ID: 28716731
[TBL] [Abstract][Full Text] [Related]
29. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract][Full Text] [Related]
30. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
31. Y-box binding protein-1 promotes hepatocellular carcinoma-initiating cell progression and tumorigenesis via Wnt/β-catenin pathway.
Chao HM; Huang HX; Chang PH; Tseng KC; Miyajima A; Chern E
Oncotarget; 2017 Jan; 8(2):2604-2616. PubMed ID: 27911878
[TBL] [Abstract][Full Text] [Related]
32. Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma.
Gui Y; Yeganeh M; Donates YC; Tobelaim WS; Chababi W; Mayhue M; Yoshimura A; Ramanathan S; Saucier C; Ilangumaran S
Oncogene; 2015 Nov; 34(46):5718-28. PubMed ID: 25728680
[TBL] [Abstract][Full Text] [Related]
33. miR-181a mediates TGF-β-induced hepatocyte EMT and is dysregulated in cirrhosis and hepatocellular cancer.
Brockhausen J; Tay SS; Grzelak CA; Bertolino P; Bowen DG; d'Avigdor WM; Teoh N; Pok S; Shackel N; Gamble JR; Vadas M; McCaughan GW
Liver Int; 2015 Jan; 35(1):240-53. PubMed ID: 24576072
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis.
Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M
Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429
[TBL] [Abstract][Full Text] [Related]
35. Deletion of HNF1α in hepatocytes results in fatty liver-related hepatocellular carcinoma in mice.
Ni Q; Ding K; Wang KQ; He J; Yin C; Shi J; Zhang X; Xie WF; Shi YQ
FEBS Lett; 2017 Jul; 591(13):1947-1957. PubMed ID: 28547778
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J
J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826
[TBL] [Abstract][Full Text] [Related]
37. p.Q511L mutation of HNF1α in hepatocellular carcinoma suppresses the transcriptional activity and the anti-tumor effect of HNF1α.
Ding CH; Deng LF; Chen F; Ding K; Chen WS; Xie WF; Zhang X
Biochem Biophys Res Commun; 2018 Jan; 495(1):86-91. PubMed ID: 29101032
[TBL] [Abstract][Full Text] [Related]
38. TGFβ overrides HNF4α tumor suppressing activity through GSK3β inactivation: implication for hepatocellular carcinoma gene therapy.
Cozzolino AM; Alonzi T; Santangelo L; Mancone C; Conti B; Steindler C; Musone M; Cicchini C; Tripodi M; Marchetti A
J Hepatol; 2013 Jan; 58(1):65-72. PubMed ID: 22960426
[TBL] [Abstract][Full Text] [Related]
39. Aquaporin 9 is down-regulated in hepatocellular carcinoma and its over-expression suppresses hepatoma cell invasion through inhibiting epithelial-to-mesenchymal transition.
Zhang WG; Li CF; Liu M; Chen XF; Shuai K; Kong X; Lv L; Mei ZC
Cancer Lett; 2016 Aug; 378(2):111-9. PubMed ID: 27216981
[TBL] [Abstract][Full Text] [Related]
40. Expression of T-cell lymphoma invasion and metastasis 2 (TIAM2) promotes proliferation and invasion of liver cancer.
Chen JS; Su IJ; Leu YW; Young KC; Sun HS
Int J Cancer; 2012 Mar; 130(6):1302-13. PubMed ID: 21469146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
